NALP1/NLRP1 Genetic Variants are Associated With Alzheimer Disease

Alzheimer disease (AD) is a complex neurodegenerative disease. Genetic and molecular studies have confirmed that in the human brain, amyloid-&bgr; fibrils can induce, through the activation of NALP1 inflammosome, inflammatory and apoptotic responses involved in the pathogenesis of AD. Considering that AD pathogenesis is multifactorial, we hypothesized that NALP1/NLRP1 could be a susceptibility gene involved in the devolvement of the disease. The possible association between 9 selected polymorphisms in the NALP1/NLRP1 gene and AD was evaluated by comparing their frequency distribution in an Italian cohort of AD patients (AD, n=276) and in a group of Italian sex-matched and age-matched healthy controls without dementia (HC, n=266). Our study, evidences the association of 4 nonsynonymous polymorphisms in the NLRP1 gene (rs2137722, rs34733791, rs11657747, rs11651595) with AD. The major alleles of all 4 single nucleotide polymorphisms and the corresponding homozygote genotypes were more frequent in AD patients than in healthy controls, suggesting an association of these variants in the predisposition versus the development of the disease. These findings seem to support the previously reported role of NALP1 in neuronal damage, and provide evidence of an association between single nucleotide variations in the NLRP1 gene and AD.

[1]  V. Pankratz,et al.  Replication of CLU, CR1, and PICALM associations with alzheimer disease. , 2010, Archives of neurology.

[2]  H. Bramlett,et al.  Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  B. Lie,et al.  A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes , 2009, Genes and Immunity.

[4]  V. Dixit,et al.  Inflammasomes: guardians of cytosolic sanctity , 2009, Immunological reviews.

[5]  A. Bianchi,et al.  Twenty years after Spinnler and Tognoni: new instruments in the Italian neuropsychologist’s toolbox , 2008, Neurological Sciences.

[6]  T. Suuronen,et al.  Amyloid-β oligomers set fire to inflammasomes and induce Alzheimer's pathology , 2008, Journal of cellular and molecular medicine.

[7]  Roger N Rosenberg,et al.  Genome-wide association studies in Alzheimer disease. , 2008, Archives of neurology.

[8]  Christine Van Broeckhoven,et al.  Molecular genetics of Alzheimer's disease: An update , 2008, Annals of medicine.

[9]  F. Martinon,et al.  Inflammasome Components NALP 1 and 3 Show Distinct but Separate Expression Profiles in Human Tissues Suggesting a Site-specific Role in the Inflammatory Response , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  E. Remmers,et al.  The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. , 2007, Arthritis and rheumatism.

[11]  Sheri L. Riccardi,et al.  NALP1 in vitiligo-associated multiple autoimmune disease. , 2007, The New England journal of medicine.

[12]  I. Appollonio,et al.  Assessing early to late stage dementia: the TSI and BANS‐S scales in the nursing‐home , 2005, International journal of geriatric psychiatry.

[13]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[14]  B. Ozenberger,et al.  Expression of NALP1 in cerebellar granule neurons stimulates apoptosis. , 2004, Cellular signalling.

[15]  J. Cummings,et al.  The Neuropsychiatric Inventory , 1997, Neurology.

[16]  N. Birbaumer,et al.  Semantic memory impairment in Alzheimer's disease. , 1996, Journal of clinical and experimental neuropsychology.

[17]  J. Grafman,et al.  Clock Drawing in Alzheimer's Disease , 1989, Journal of the American Geriatrics Society.

[18]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[19]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[20]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[21]  S. Katz,et al.  Progress in development of the index of ADL. , 1970, The Gerontologist.

[22]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[23]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[24]  J. Wade,et al.  The clinical diagnosis of Alzheimer's disease. , 1987, Archives of neurology.

[25]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.